
Basilea Pharmaceutica Investor Relations Material
Latest events

H1 2025
Basilea Pharmaceutica
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Basilea Pharmaceutica AG
Access all reports
Basilea Pharmaceutica AG is a biopharmaceutical company specializing in the research, development, and commercialization of hospital anti-infectives and oncology medicines. It focuses on therapies addressing antimicrobial resistance and cancer. The company is headquartered in Basel, Switzerland, and its shares are listed on the SIX Swiss Exchange.
Key slides for Basilea Pharmaceutica AG


H2 2024
Basilea Pharmaceutica AG


H1 2025
Basilea Pharmaceutica AG
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
BSLN
Country
🇨🇭 Switzerland